DE60239690D1 - Sezernierte und zelloberflächengene, die in gutartigen und bösartigen kolorektaltumoren exprimiert werden - Google Patents

Sezernierte und zelloberflächengene, die in gutartigen und bösartigen kolorektaltumoren exprimiert werden

Info

Publication number
DE60239690D1
DE60239690D1 DE60239690T DE60239690T DE60239690D1 DE 60239690 D1 DE60239690 D1 DE 60239690D1 DE 60239690 T DE60239690 T DE 60239690T DE 60239690 T DE60239690 T DE 60239690T DE 60239690 D1 DE60239690 D1 DE 60239690D1
Authority
DE
Germany
Prior art keywords
rdp
mastile
colorektumumors
separated
good
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60239690T
Other languages
German (de)
English (en)
Inventor
Phillip Buckhaults
Kenneth W Kinzler
Bert Vogelstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Application granted granted Critical
Publication of DE60239690D1 publication Critical patent/DE60239690D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/495Transforming growth factor [TGF]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Walking Sticks, Umbrellas, And Fans (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60239690T 2001-09-07 2002-09-09 Sezernierte und zelloberflächengene, die in gutartigen und bösartigen kolorektaltumoren exprimiert werden Expired - Lifetime DE60239690D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31749401P 2001-09-07 2001-09-07
US38380502P 2002-05-30 2002-05-30
PCT/US2002/028518 WO2003022863A1 (en) 2001-09-07 2002-09-09 Secreted and cell surface genes expressed in benign and malignant colorectal tumors

Publications (1)

Publication Number Publication Date
DE60239690D1 true DE60239690D1 (de) 2011-05-19

Family

ID=26980985

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60239690T Expired - Lifetime DE60239690D1 (de) 2001-09-07 2002-09-09 Sezernierte und zelloberflächengene, die in gutartigen und bösartigen kolorektaltumoren exprimiert werden

Country Status (6)

Country Link
US (1) US8029764B2 (enExample)
EP (1) EP1430071B1 (enExample)
JP (1) JP2005518781A (enExample)
AT (1) ATE504594T1 (enExample)
DE (1) DE60239690D1 (enExample)
WO (1) WO2003022863A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003254185A1 (en) * 2002-07-27 2004-02-16 The Johns Hopkins School Of Medicine Design and synthesis of renal dipeptidase inhibitors
WO2006066916A1 (en) * 2004-12-23 2006-06-29 Roche Diagnostics Gmbh Use of microsomal dipeptidase as a marker for colorectal cancer
KR20090003149A (ko) 2005-09-30 2009-01-09 안티캔서, 인코포레이티드 인간 암의 초기, 암의 진행 및 재발 마커의 동정 방법
CA2688558A1 (en) * 2007-06-04 2009-03-26 Diagnoplex Biomarker combinations for colorectal cancer
MX2012004721A (es) 2009-10-23 2012-06-25 Mannkind Corp Inmunoterapia de cancer y metodo de tratamiento.
US20160235778A1 (en) * 2014-03-13 2016-08-18 Massachusetts Institute Of Technology Compositions containing pufa, uridine and choline and methods of use thereof
US20160209415A1 (en) * 2015-01-20 2016-07-21 Poochon Scientific LLC Method to predict or diagnose a colorectal cancer
US9689874B2 (en) 2015-04-10 2017-06-27 Applied Proteomics, Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
CN105603093A (zh) * 2016-02-05 2016-05-25 广州复能基因有限公司 以MIC-1 cDNA为模板制备RNA探针的方法
CN109402119A (zh) * 2018-12-11 2019-03-01 宁夏医科大学总医院 一种环状RNA hsa_circTGFBI_001及其特异性扩增引物和应用
CN109402125A (zh) * 2018-12-11 2019-03-01 宁夏医科大学总医院 一种环状RNA hsa_circTGFBI_007及其特异性扩增引物和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7499198A (en) * 1997-05-21 1998-12-11 Johns Hopkins University, The Gene expression profiles in normal and cancer cells

Also Published As

Publication number Publication date
JP2005518781A (ja) 2005-06-30
US20040265824A1 (en) 2004-12-30
ATE504594T1 (de) 2011-04-15
EP1430071A4 (en) 2005-11-02
WO2003022863A1 (en) 2003-03-20
EP1430071B1 (en) 2011-04-06
EP1430071A1 (en) 2004-06-23
US8029764B2 (en) 2011-10-04

Similar Documents

Publication Publication Date Title
WO2004060302A3 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
WO2002009573A3 (en) Prognostic classification of endometrial cancer
DE60239690D1 (de) Sezernierte und zelloberflächengene, die in gutartigen und bösartigen kolorektaltumoren exprimiert werden
WO2004027432A3 (en) Prognostic methods for patients with prostatic disease
WO2004086949A3 (en) Dna markers for management of cancer
WO2006008128A3 (en) Epigenetic methods and nucleic acids for the detection of breast cell proliferative disorders
AU2004205878A8 (en) Gene expression markers for breast cancer prognosis
AU2001249548A1 (en) Compositions and methods for identifying and targeting cancer cells
EP2062918A3 (en) Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
AU2002252144A1 (en) Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer
EP1492440B8 (en) A new method for the diagnosis and prognosis of malignant diseases
CA2425761A1 (en) Non-invasive enzyme screen for tissue remodelling-associated conditions
WO2002044331A3 (en) Dap-kinase and hoxa9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer
WO2006089233A3 (en) Methods and systems for diagnosis, prognosis and selection of treatment of leukemia
AU9635901A (en) Isoprenoid production
WO2004097052A3 (en) Methods for prognosis and treatment of solid tumors
AU2002303444A1 (en) Detection of microsatellite instability and its use in diagnosis of tumors
EP1910838A4 (en) SPECIFIC CANCER GLYCANS AND THEIR USE
AU2003227532A1 (en) Mononucleotide repeats microsatellite markers for detecting microsatellite instability.
WO2005007097A3 (en) Breast cancer genes
WO2002076286A3 (en) Prognostic methods for breast cancer
WO2001030967A3 (en) Fluorescent cobalamins and uses thereof
WO2004084804A3 (en) Detection and monitoring of lung cancer
WO2002080844A3 (en) Novel bgp compounds for therapy and diagnosis and methods for using same
WO2004080271A3 (en) Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof